{"id":"W2100530570","doi":"10.1177/193229680900300440","title":"Antisense Oligonucleotide Therapy in Diabetic Retinopathy","year":2009,"lang":"en","type":"review","venue":"Journal of Diabetes Science and Technology","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"iCo Therapeutics (Canada)","funders":"","keywords":"Diabetic retinopathy; Medicine; Vitrectomy; Blindness; Diabetes mellitus; Intravitreal administration; Ophthalmology; Retinopathy; Angiogenesis; Macular edema; PEDF; Bevacizumab; Intensive care medicine; Pharmacology; Bioinformatics; Optometry; Surgery; Internal medicine; Retinal; Endocrinology; Chemotherapy; Biology; Visual acuity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003866715,0.0008895454,0.001208249,0.002031366,0.0002540348,0.0005362598,0.0006032297,0.0009887057,0.002645963],"category_scores_gemma":[0.0004101289,0.0002145507,0.0004369282,0.001794605,0.0003735999,0.0008092722,0.0004444168,0.001544081,0.001924024],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00046065,"about_ca_system_score_gemma":0.0005066405,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001010454,"about_ca_topic_score_gemma":0.001862025,"domain_scores_codex":[0.999838,0.00002644697,0.00002098814,0.00002726292,0.00007208103,0.00001522036],"domain_scores_gemma":[0.9998431,0.00006966409,0.00002366678,0.000004759183,0.00004310461,0.00001552866],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008480557,0.0001247827,0.0001507554,0.008285611,0.00005298799,0.0003525329,0.00005267742,0.0002918523,0.005566116,0.001841411,0.01997071,0.9632258],"study_design_scores_gemma":[0.00004701538,0.0002216033,0.001137835,0.002377907,0.0001020412,0.003210577,0.00004740596,0.0001093889,0.0019291,0.001598468,0.9891972,0.00002143046],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000210037,0.9983292,0.000132376,0.00008443597,0.0001955321,0.00000514662,0.000007130773,0.000007239613,0.001028896],"genre_scores_gemma":[0.001255326,0.997106,0.0002348533,0.0001639283,0.0001328333,0.000007768552,0.00002336558,0.00000153336,0.001074474],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002645963,"threshold_uncertainty_score":0.008851647,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02206311983067781,"score_gpt":0.3248705097615002,"score_spread":0.3028073899308224,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}